CORPORATION (OTCMKTS:CCYPQ) Files An 8-K Regulation FD DisclosureItem 7.01
On March27, 2018, representatives of RXi Pharmaceuticals Corporation participated in the Landmark Venture Forum in Old Greenwich, Connecticut. A copy of the presentation to be used during the conference is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The information in this Item 7.01 and attached as Exhibit 99.1 to this Current Report on Form 8-K will not be treated as “filed” for the purposes of Section18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. This information will not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or into another filing under the Exchange Act, unless that filing expressly incorporates this information by reference.
| Item 7.01 | Financial Statements and Exhibits. |
(d) Exhibits
| 99.1 | Conference Presentation, dated March27, 2018. |
* * *
RXi Pharmaceuticals Corp ExhibitEX-99.1 2 d556334dex991.htm EX-99.1 EX-99.1 RXi Pharmaceuticals NASDAQ: RXII Dr. Geert Cauwenbergh,…To view the full exhibit click here